✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Bacil Pharma Ltd.

BACPHAR

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹47 Cr.
P/E
74.63

Bacil Pharma Ltd.

  • Bacil Pharma
  • Bandaram Pharma Pack
  • JFL Life Sciences

FAQs on Bacil Pharma Ltd. Shareprice

Bacil Pharma has given better returns compared to its competitors.
Bacil Pharma has grown at ~64.73% over the last 3yrs while peers have grown at a median rate of -6.0%

There is insufficient historical data to gauge this.
Latest PE of Bacil Pharma is 71.43

View FAQ's On Business

Growth Table

  • Bacil Pharma Ltd.
  • Bandaram Pharma Pack
  • JFL Life Sciences

Balance Sheet

  • Bacil Pharma Ltd.
  • Bandaram Pharma Pack
  • JFL Life Sciences

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Bacil Pharma Ltd.
  • Bandaram Pharma Pack
  • JFL Life Sciences

Cash Flow

  • Bacil Pharma Ltd.
  • Bandaram Pharma Pack
  • JFL Life Sciences

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Bacil Pharma Ltd.
  • Bandaram Pharma Pack
  • JFL Life Sciences

Quarterly Results

  • Bacil Pharma Ltd.
  • Bandaram Pharma Pack
  • JFL Life Sciences

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Bacil Pharma Ltd. Financials

Bacil Pharma balance sheet is weak and might have solvency issues

Yes, The net debt of Bacil Pharma is increasing.
Latest net debt of Bacil Pharma is -₹1.59 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹5.48 Crs.

Yes, profit is increasing.
The profit of Bacil Pharma is ₹0.4 Crs for Mar 2025, -₹0.06 Crs for Mar 2024 and -₹0.1 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Bacil Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech